EOLS
EOLS
NASDAQ · Pharmaceuticals

Evolus Inc

$6.63
-0.11 (-1.63%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +673.6% upside
Low Target $37.24
Average Target $51.29
High Target $70.77
Current Price $6.63
Current
$6.63
Target
$51.29
$37.24 $51.29 avg $70.77
Scenario Analysis
Bear Case
$37.24
461.7%
Low target
Base Case
$51.29
+673.6%
Avg target
Bull Case
$70.77
+967.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$10.20
-35.0% from high
52-Week Low
$3.86
+71.8% from low
Target vs 52W High
$51.29
+402.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%